Kenalog

ANDA 83943, held by Delcor Asset Corp. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 83943 (Kenalog), held by Delcor Asset Corp, was first approved by FDA on Jan 29, 1974, with 9 approved supplements and 0 published complete response letters.

First approved: Jan 29, 1974
Supplements approved: 9
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 10 submissions below

Date	Submission	Status	Documents
Jan 29, 1974	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Kenalog0.5% · cream;topical	Triamcinolone Acetonide	DiscontinuedReference drug

All 10 submissions, including labeling and manufacturing supplements


May 14, 1996	Supplement 35Manufacturing	Approved	None posted
Apr 4, 1988	Supplement 34Labeling	Approved	None posted
Feb 10, 1988	Supplement 31Manufacturing	Approved	None posted
Jun 6, 1986	Supplement 28Manufacturing	Approved	None posted
Mar 8, 1984	Supplement 27Manufacturing	Approved	None posted
May 27, 1983	Supplement 26Manufacturing	Approved	None posted
Jun 23, 1982	Supplement 19Manufacturing	Approved	None posted
Apr 1, 1982	Supplement 24Manufacturing	Approved	None posted
Apr 1, 1982	Supplement 23Manufacturing	Approved	None posted
Jan 29, 1974	Original application	Approved	None posted

Identifiers

Application: ANDA 83943
Drugs@FDA: Overview at FDA
Company: Delcor Asset Corp.

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters